AC Immune SA

Healthcare · Biotechnology · Switzerland

Last price 2.22 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 220.73M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. The company’s SupraAntigen and Morphomer platforms are designed to generate biologics and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. It develops Crenezumab, a humanized, conformation specific monoclonal antibody used to slow A...